Life ScienceCompany
Open Monoclonal Technology Ownership
Who owns Open Monoclonal Technology?
Open Monoclonal Technology is owned by Ligand Pharmaceuticals. It was acquired on December 17, 2015.
Was Open Monoclonal Technology formerly PE-backed?
Yes. Open Monoclonal Technology was formerly owned by 1 private investor.
Open Monoclonal Technology Business Overview
Where is Open Monoclonal Technology headquartered?
Open Monoclonal Technology is headquartered in Palo Alto, California.
What sector is Open Monoclonal Technology in?
Open Monoclonal Technology is a life science company.
When was Open Monoclonal Technology founded?
Open Monoclonal Technology was founded in 2007.
Life Science M&A Summary in 2015
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.
Join Mergr to view all 293 acquisitions of life science companies in 2015, including 31 acquisitions by private equity firms, and 262 by strategics.